Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.
about
Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatmentPulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.Pulmonary hypertension in the young.Nitric oxide and prostaglandins potentiate the liver regeneration cascade.Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
P2860
Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment with epoprostenol re ...... rimary pulmonary hypertension.
@ast
Treatment with epoprostenol re ...... rimary pulmonary hypertension.
@en
type
label
Treatment with epoprostenol re ...... rimary pulmonary hypertension.
@ast
Treatment with epoprostenol re ...... rimary pulmonary hypertension.
@en
prefLabel
Treatment with epoprostenol re ...... rimary pulmonary hypertension.
@ast
Treatment with epoprostenol re ...... rimary pulmonary hypertension.
@en
P2093
P2860
P356
P1433
P1476
Treatment with epoprostenol re ...... rimary pulmonary hypertension.
@en
P2093
Kopatschka J
Stiebellehner L
Wittmann K
P2860
P304
P356
10.1136/HEART.83.4.406
P407
P577
2000-04-01T00:00:00Z